Shiseido
VC Fund
Tokyo, Japan
Shiseido is a VC fund in Tokyo focused on Health Care and Biotechnology. Shiseido was founded in 1872 as the first Western-style pharmacy in Japan. The business gradually evolved into a cosmetics company, offering people the most advanced technology and the finest aesthetics available in the East or the West. Now known globally as the premier cosmetics company with roots in Japan, the name Shiseido has come to representthe world’s highest standards of quality. Shiseido’s global selection of skincare, makeup and fragrance includes a high-performance category for special skincare, and a brightening line. Shiseido also offers body care, suncare and a skincare line for men. Fiercely contemporary and innovative after over 140 years in business, Shiseido group brands are now sold in over 120 countries and regions.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Shiseido invests in
Stages Shiseido invests in
Countries Shiseido invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jennifer Heitmeyer
|
|||
Masahiko Uotani
|
|||
Welington Fonseca
|
|||
Arinobu Fukuhara
|
|||
Investment Focus
Industry
- Health Care 3 (38%)
- Biotechnology 3 (38%)
- Medical 2 (25%)
- Wellness 2 (25%)
- Beauty 1 (13%)
Stage
- Series A 3 (38%)
- Seed 1 (13%)
- Series D 1 (13%)
- Post-IPO Equity 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- Japan 2 (25%)
- China 1 (13%)
- France 1 (13%)
- Taiwan 1 (13%)
- United States 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jennifer Heitmeyer
Executive Director, Retail
|
Executive Director, Retail | Total investments: 0 | Find email | |
|
Masahiko Uotani
President & CEO
|
President & CEO | Total investments: 1 | Find email | |
|
Welington Fonseca
SVP, Global Customer Marketing
|
SVP, Global Customer Marketing | Total investments: 0 | Find email | |
|
Arinobu Fukuhara
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Chitose Group
|
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. | $28.6M / Venture - Series Unknown / Mar 10, 2025 | |
Phyla
|
Phyla is developing alternative therapies for antibiotics. The focus of most microbiome efforts is to discover beneficial bacteria to add to the microbiome, in order to cure disease or maintain health. However others lack a subtractive function that can remove harmful or disease-causing bacteria, that would allow the microbiome to rebalance andachieve a stable healthy state. Using bacteriophages as a foundation, they are developing a powerful platform that allows us to selectively 'subtract' bad bacteria without harming the good strains present in the community. It's a bit like using a sniper instead of a grenade to take out a bad guy in a crowd of people. | Series A / Dec 07, 2023 | |
|
Chitose Group
|
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. | $22.5M / Venture - Series Unknown / Jul 13, 2023 | |
Perfect
|
Perfect Corp. is dedicated to transforming how consumers, content creators and beauty brands interact together. Their unique platform is the premier online destination for all beauty lovers. Their apps, YouCam Makeup, recently voted Best Fashion & Apparels App* of 2015, and market-leading YouCam Perfect redefine virtual beauty for tens ofmillions of users. Their experienced team of engineers and beauty aficionados is pushing the frontiers of technology to create the beauty platform of the future – a fluid environment where individuals express themselves, learn the latest about fashion and beauty, and enjoy instant access to the products from their favorite brands.*YouCam Makeup is the winner of 2015 Appy Award of Best Fashion & Apparels App. | $105M / Post-IPO Equity / Oct 28, 2022 | |
Chuangjian Medical
|
Chuangjian Medical is a technological innovation company that focuses on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines. | $29.7M / Series A / Aug 10, 2022 | |
Airfree SAS
|
Airfree SAS specialized respectively in duty-free commerce, technology, digital and e-commerce. | Series A / May 27, 2019 | |
FiNC Technologies
|
FiNC Technologies is a health tech company specializing in AI-driven wellness solutions. Their platform combines data analysis, rich content, and social elements to assist users in logging, understanding, managing, and improving their health and wellness. It empowers individuals to achieve their health goals effectively by leveraging machinelearning and personalized coaching. | $779.6M / Series D / Sep 20, 2018 | |
|
Airfree SAS
|
Airfree SAS specialized respectively in duty-free commerce, technology, digital and e-commerce. | Seed / May 01, 2017 |
Co-Investors
Amano Enzyme
2 deals together
Ikeda Saccharification Industry
2 deals together
Mers Line
2 deals together
Mitsui Mining & Smelting
2 deals together
NGK Insulators
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Shiseido invest in?
Shiseido invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Shiseido?
Public channels for Shiseido include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Shiseido?
The team at Shiseido includes Jennifer Heitmeyer (Executive Director, Retail), Masahiko Uotani (President & CEO) and Welington Fonseca (SVP, Global Customer Marketing). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
